Veterinary Medicines

LABIASOL AD3E-500, (500+75+50)IU/ML ενέσιμο εναιώρημα για ιπποειδή, βοοειδή, πρόβατα, αίγες και χοίρους

Authorised
  • Retinol
  • Colecalciferol
  • DL-ALPHA-TOCOPHEROL
Download as PDF

Product identification

Medicine name:
LABIASOL AD3E-500, (500+75+50)IU/ML ενέσιμο εναιώρημα για ιπποειδή, βοοειδή, πρόβατα, αίγες και χοίρους
Active substance:
  • Retinol
  • Colecalciferol
  • DL-ALPHA-TOCOPHEROL
Target species:
  • Cattle
  • Sheep
  • Goat
  • Pig
  • Horse
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Retinol
    500000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • Colecalciferol
    75000.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • DL-ALPHA-TOCOPHEROL
    50.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        280
        day
      • Milk
        120
        hour
    • Sheep
      • Meat and offal
        243
        day
      • Milk
        120
        hour
    • Goat
      • Meat and offal
        243
        day
      • Milk
        120
        hour
    • Pig
      • Meat and offal
        259
        day
    • Horse
      • Meat and offal
        280
        day
      • Milk
        120
        hour
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QA11A
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Hellafarm S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Labiana Life Sciences S.A.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 7761/17-03-1993/K-0071001
Date of authorisation status change: